Kamada KMDA
NASDAQ KMDA
$8.21 -0.08 (-0.97%)
As of: Sep 9, 2026 · 3:35 PM EDT

Kamada (KMDA) Depreciation & Amortization - Total (2012 - 2025)

Kamada's (KMDA) quarterly Depreciation & Amortization - Total came in at $3.8 million in Q4 2025, up 8.32% on a YoY basis from $3.5 million in Q4 2024, and up 8.32% quarter-over-quarter from $3.5 million in Q4 2024.

Analysis

Kamada (KMDA) Depreciation & Amortization - Total (2012 - 2025) Analysis & Trends

Kamada (KMDA) has reported Depreciation & Amortization - Total for 12 consecutive years, with $3.8 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization - Total rose 8.32% year-over-year to $3.8 million; the trailing twelve-month figure through Dec 2025 stood at $13.5 million (up 7.26% YoY), and the FY2025 full-year result was $14.9 million, up 12.91% from the prior year.
  • Depreciation & Amortization - Total improved to $3.8 million in Q4 2025 per KMDA's latest filing, from $3.5 million in the prior quarter.
  • Across five years, Depreciation & Amortization - Total topped out at $3.8 million in Q4 2025 and bottomed at $1.1 million in Q1 2021.
  • Historically, Depreciation & Amortization - Total has averaged $2.8 million across 5 years, with a median of $3.0 million in 2022.
  • The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization - Total jumped 151.61% in 2022, then rose 6.51% in 2023.
  • Over 5 years, Depreciation & Amortization - Total stood at $2.0 million in 2021, then jumped by 50.83% to $3.0 million in 2022, then advanced by 6.51% to $3.2 million in 2023, then advanced by 9.41% to $3.5 million in 2024, then gained by 8.32% to $3.8 million in 2025.
  • According to Business Quant data, Depreciation & Amortization - Total over the past three periods registered $3.8 million, $3.5 million, and $3.2 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Tot) (Qtr)
1 Amgen 211.77 Bn 197.79 Bn 7.24 Bn -
2 Gilead Sciences 181.13 Bn 177.95 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 132.24 Bn 124.39 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 82.89 Bn 74.89 Bn 3.93 Bn -
5 Argenx Se 61.56 Bn 56.38 Bn 1.37 Bn -
6 Moderna 54.38 Bn 49.24 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 34.44 Bn 31.13 Bn 992.69 Mn -
8 Biogen 31.17 Bn 29.89 Bn 1.96 Bn -
9 Roivant Sciences 30.12 Bn 30.12 Bn 1.16 Mn -
10 Kamada 473.28 Mn 403.14 Mn 22.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 3.80 Mn
Dec 31, 2024 3.51 Mn
Dec 31, 2023 3.21 Mn
Dec 31, 2022 3.01 Mn
Mar 31, 2022 2.89 Mn
Dec 31, 2021 2.00 Mn
Mar 31, 2021 1.15 Mn
Dec 31, 2020 1.27 Mn
Sep 30, 2020 1.25 Mn
Jun 30, 2020 1.19 Mn
Dec 31, 2019 1.14 Mn
Sep 30, 2019 1.13 Mn
Jun 30, 2019 1.12 Mn
Jun 30, 2016 1.71 Mn
Mar 31, 2016 831,000.00
Sep 30, 2015 2.44 Mn
Jun 30, 2015 1.57 Mn
Mar 31, 2015 771,000.00
Sep 30, 2014 2.04 Mn
Jun 30, 2014 1.32 Mn